MedPath
TGA Approval

VOTRIENT pazopanib 400 mg tablet bottle (161281)

161281

VOTRIENT pazopanib 400 mg tablet bottle

Novartis Pharmaceuticals Australia Pty Ltd

June 30, 2010

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-CMI-01920-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-07077-3

Active Ingredients

pazopanib hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VOTRIENT pazopanib 400 mg tablet bottle (161281) - TGA 批准文号 | MedPath